These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8420262)

  • 21. [Can the recurrence of hepatitis B after liver transplantation be prevented?].
    Casafont F; Pons Romero F
    Gastroenterol Hepatol; 1996 Dec; 19(10):521-3. PubMed ID: 9044754
    [No Abstract]   [Full Text] [Related]  

  • 22. [De novo hepatitis B infection after liver transplantation--evidence for the need of active hepatitis B vaccination of liver transplantation candidates].
    Rambusch EG; Nashan B; Tillmann HL; Böker KH; Schlitt HJ; Maschek H; Raab R; Manns MP
    Z Gastroenterol; 1998 Dec; 36(12):1027-35. PubMed ID: 10025054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prevention and treatment of hepatitis B virus reinfection after liver transplantation].
    Lu MQ; Cai CJ; Zhao H; Yang Y; Chen GH
    Zhonghua Wai Ke Za Zhi; 2006 Jun; 44(11):742-4. PubMed ID: 16836920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. No hepatitis recurrence using combination prophylaxis in HBV-positive liver transplant recipients with YMDD mutants.
    Caccamo L; Romeo R; Rossi G; Maggioni M; Radice F; Lunghi G; Colombo M; Fassati LR
    Transpl Int; 2005 Feb; 18(2):186-92. PubMed ID: 15691271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylaxis and treatment of recurrent hepatitis B after liver transplantation.
    Lo CM; Fan ST; Liu CL; Lai CL; Wong J
    Transplantation; 2003 Feb; 75(3 Suppl):S41-4. PubMed ID: 12589139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Living donor liver transplantation for hepatitis B associated liver diseases: a 10-year experience in a single center.
    Ikegami T; Soejima Y; Ohta R; Taketomi A; Yoshizumi T; Harada N; Kayashima H; Maehara Y
    Hepatogastroenterology; 2008; 55(85):1445-9. PubMed ID: 18795708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Management of hepatitis B in liver transplant patients.
    Mohanty SR; Cotler SJ
    J Clin Gastroenterol; 2005 Jan; 39(1):58-63. PubMed ID: 15599213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B vaccination after liver transplantation.
    Sanchez-Fueyo A; Martinez-Bauer E; Rimola A
    Hepatology; 2002 Jul; 36(1):257-8; author reply 258-9. PubMed ID: 12085376
    [No Abstract]   [Full Text] [Related]  

  • 29. [Preventive lamivudine against reinfection by hepatitis B after liver transplantation].
    Niederau C
    Z Gastroenterol; 1997 May; 35(5):359-61. PubMed ID: 9265396
    [No Abstract]   [Full Text] [Related]  

  • 30. The effects of glycyrrhizin on cholecystography and on the bile excretion.
    Ayabe K; Kuratomi A; Tani M
    Fukuoka Igaku Zasshi; 1974 Apr; 65(4):193-204. PubMed ID: 4472363
    [No Abstract]   [Full Text] [Related]  

  • 31. [A case of glycyrrhizin poisoning in a hypertensive patent].
    Plauchu M; Lachieze-Rey E; Monnet R; Dazord A; Berger G
    Lyon Med; 1969 Mar; 221(9):445-9. PubMed ID: 5360533
    [No Abstract]   [Full Text] [Related]  

  • 32. [Glycyrrhizin and apparently essential arterial hypertension (5 cases)].
    Froment A; Dupont JC; Milon H; Froment R
    Arch Mal Coeur Vaiss; 1968 May; 61(5):637-56. PubMed ID: 4971368
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pseudoaldosteronism induced by administration of a massive dose of glycyrrhizin].
    Hanasaki N; Katoo H; Shinomura Y; Nakao K; Morimoto Y
    Nihon Rinsho; 1976 Feb; 34(2):390-4. PubMed ID: 944301
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cardiovascular effects of the consumption of weak doses of glycyrrhizin. Preliminary results obtained during an epidemiologic survey].
    Milon H; Froment A
    Rev Lyon Med; 1968 Nov; 17(17):781-4. PubMed ID: 5715705
    [No Abstract]   [Full Text] [Related]  

  • 35. [Glucuronide formation from glycyrrhizin and anthranilic acid by the catalytic action of beta-glucuronidase].
    Saito K; Yamazoe S
    Igaku To Seibutsugaku; 1966 Apr; 70(4):236-9. PubMed ID: 5949463
    [No Abstract]   [Full Text] [Related]  

  • 36. [Cerebral disorders and their treatment].
    Hochrein M; Schleicher I
    Med Monatsschr; 1972 Jan; 26(1):14-8. PubMed ID: 5022577
    [No Abstract]   [Full Text] [Related]  

  • 37. [Determination of glycyrrhizin and glycyrrhizinic acid in serum].
    Taguchi T
    Seikagaku; 1968 Nov; 40(11):817-23. PubMed ID: 5752200
    [No Abstract]   [Full Text] [Related]  

  • 38. [A new anti-gastralgic agent].
    Dornier R
    Gaz Med Fr; 1965 Dec; 72(23):4191-3. PubMed ID: 5854805
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical test of a "polyvalent liver protector" on various diffuse liver diseases of prolonged evolution].
    Rocha A; Cortizas JL; Franco M; Salom R
    Rev Esp Enferm Apar Dig; 1969 Oct; 29(3):449-62. PubMed ID: 5343981
    [No Abstract]   [Full Text] [Related]  

  • 40. [The effects of ingestion of moderate quantities of liquorice].
    Gøtzsche PC; Gjørup IE
    Ugeskr Laeger; 1983 Dec; 145(50):3902-4. PubMed ID: 6364518
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.